General Experimental
Unless otherwise stated, all chemical reagents and solvents were purchased from commercial sources and used without further purification. Doxorubicin hydrochloride salt was purchased from AK Scientific, California. 5-Hydroxy-1-cyclooctene (cis-cyclooct-4-enol) was purchased from Carbosynth Limited, UK. Silver nitrate-impregnated silica gel was purchased from SigmaAldrich and Silicycle (SiliaBond ® Silver Nitrate, 40-63μm, 60Å). Powdered molecular sieves were activated in an oven at 180 °C overnight before use and then stored at 110 °C. All other reagents were purchased from Sigma-Aldrich or AK Scientific. Reaction solvents were Fluorescence data were recorded on a Hitachi F-7000 Fluorescence Spectrofluorometer.
Excitation was at 360 nm and emission monitored in the range of 400 -650 nm ( max = 455 nm).
Default settings were selected for other parameters.
HPLC was performed using either an Agilent 1200 system or Shimadzu 20 series system, equipped with a Phenomenex Synergi 4 m Fusion-RP 80A (150 x 4.6 mm) column, and a photodiode array detector. The applied mobile phases used for kinetic studies and purity determinations were: A, aq H 2 O + 0.1% formic acid; and B, aq MeCN + 0.1% formic acid. Flow speed was 1 mL/min and injection volumes were 20 µl or 50 µl. Gradient mobile phase, 80% H 2 O/20% MeCN with 0.1% formic acid to 100% MeCN with 0.1% formic acid in 10 minutes, 5 minutes at 100% MeCN with 0.1% formic acid, returning to starting conditions by 20 minutes. 1 The synthesis of 4-azidobenzyl alcohol was performed using a known literature procedure. 1 4-Aminobenzyl alcohol (0.602 g, 4.89 mmol) was dissolved in 5 mL of 5M HCl. The solution was cooled to 0 °C on ice, followed by dropwise addition of a NaNO 2 (0.363 g, 5.26 mmol) solution in 10 mL of water. The reaction was allowed to stir for 30 min at 0 °C, upon which time NaN 3 (1.37 g, 21.1 mmol) was added in portions (solution maintained at 0 °C in an ice bath). The reaction mixture was stirred at 0 °C for 1.5 h, before pouring into an ice-water slurry (~ volume of 50 mL). The solution was adjusted to a pH of ~ 8 with solid NaHCO 3 , and extracted with ethyl acetate (2 x 50 mL). The combined organic layers were washed with water (3 x 30 mL), dried (MgSO 4 ) and concentrated in vacuo (temperature maintained below 30 °C). The oily residue was suspended in petroleum ether (20 mL, b.p. 40-60 °C) and stirred vigorously for 30 min, before being stored in the freezer overnight. Upon removal from the freezer, the precipitate was filtered to provide the azide as a mixture of yellow-brown solid and fine beige colored needles (0.541 g, 73%), which were spectroscopically similar to that previously reported. 
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Synthesis
4-azidobenzyl alcohol
4-azidobenzyl-4′-nitrophenyl carbonate 1
The synthesis of 4-azidobenzyl-4-nitrophenyl carbonate was performed using a modified literature procedure. 1 To a solution of 4-nitrophenyl chloroformate (0.243 g, 1.21 mmol) in anhydrous THF (5 mL) was added pyridine (0.146 mL, 1.81 mmol). The solution was cooled to 0 °C and a solution of 4-azidobenzyl alcohol (0.135 g, 0.905 mmol) in anhydrous THF (8 mL) was added dropwise over 15 min. The solution was allowed to warm to 25 °C and stirred in the dark for 72 h under nitrogen, after which time TLC analysis indicated that the reaction was complete. The THF was removed in vacuo, and the crude residue re-dissolved in ethyl acetate (30 mL), which was washed with water (2 x 30 mL), brine (5 x 30 mL), dried (MgSO 4 ) and concentrated in vacuo (temperature maintained below 30 °C). The crude residue was subjected to 
S4
flash silica gel column chromatography (50% DCM:hexanes) to afford the title compound as a yellow solid (0.161 g, 57%), which was spectroscopically identical to that reported in the 
4-azidobenzyl (2-oxo-2H-chromen-7-yl) carbonate (8a)
To a solution of 4-azidobenzyl-4-nitrophenyl carbonate (19.6 mg, 0.0624 mmol) in anhydrous DMF (1 mL) was added 7-hydroxycoumarin (19.4 mg, 0.133 mmol) and triethylamine (35 L, 0.255 mmol). The reaction mixture was stirred in the dark at 25 °C under an atmosphere of nitrogen for 24 h, after which time the DMF was diluted with water and extracted with ethyl acetate (3 x 20 mL). The combined organic fractions were washed with water (2 x 30 mL), brine (3 x 30 mL), dried (MgSO 4 ), and concentrated in vacuo (temperature maintained below 30 °C).
The crude residue was subjected to flash silica gel column chromatography (25% ethyl acetate:hexanes) to provide the title compound 8a as a white solid (10 mg, 48%). Small amounts of 4-nitrophenol co-eluted with the product, but these were removed through rinsing with ice cold methanol (product is partially soluble in methanol) or performing a miniature liquid-liquid extraction (ethyl acetate:water). Following the liquid-liquid extraction, the product was isolated as a white solid (8 mg, 38%), and was used in the spectrofluorometry, HPLC and NMR studies. 
4-Azidobenzyl carbamate doxorubicin (9) 1
The doxorubicin prodrug 9 was synthesized using a modified procedure. 1 trans-Cyclooctene (TCO) was synthesized using a modified literature procedure. 2 To a 250 mL quartz reaction vessel was added cis-cyclooctene (0. Figure 2 Figure   2 ): Stock solutions of coumarin probe 8b (1.25 mM, Stock 4), and TCO-OH major-10 (50 mM, Stock 5) were prepared in acetonitrile (HPLC grade or CD 3 CN). The same experimental procedure as above was carried out with the final concentration of 0.5 mM for 8b and 5 mM for TCO-OH major-10. The solutions were incubated at 37 °C and at the relevant time point, a 50 µl aliquot was taken from each of the three reaction solutions and diluted separately in PBS (2950 L, 60 x dilution). The PBS solution was vortexed briefly, transferred to a plastic cuvette and the fluorescence measured at 455 nm (Ex 360 nm). The experiment was repeated for a total of three runs (n = 3).
Spectrofluorometry Release Experiments
Procedure of a typical experiment for release of 7-hydroxycoumarin 13a (data in
Procedure of a typical experiment for release of 7-amino-4-methylcoumarin 13b (data in
To calculate the amount of fluorescence (relative release from probe 8a/8b), a standard curve of 7-hydroxycoumarin 13a and 7-amino-4-methylcoumarin 13b was measured in 1 x PBS (stocks prepared in acetonitrile:PBS (1:1) and diluted 1000-fold in 1 x PBS). The height at the  max (455 S10 nm) was used to generate a standard curve for 7-hydroxycoumarin 13a ( Figure S1 ) and 7-amino-4-methylcoumarin 13b ( Figure S2 ). From the standard curve, the fluorescence for the maximum amount of coumarin which could be released from probe 8a was 1191.8 units (8.33 M in 60 x diluted solution) and for 8b, 1658.5 units (8.33 µM in 60 x diluted solution). reaction. An aliquot of NMR sample containing triazoline 11b (3 μL) was further diluted into PBS (2997 μL, 1000 x dilution) and was subjected to the triazoline and imine degradation. The PBS solution was vortexed briefly, transferred to a plastic cuvette and the fluorescence was scanned over 3600 seconds at 455 nm (Ex 360 nm). The experiment was repeated for a total of three runs (n = 3).
To calculate the amount of fluorescence (relative release from probe 8b), a standard curve of coumarin was measured. The height at the λ max (455 nm) was used to generate a standard curve for 7-amino-4-methylcoumarin ( Figure S2 ). From the standard curve ( Figure S2 ), the fluorescence for the maximum amount of coumarin which could be released from probe 8b was 1595.7 units (8 μM in 1000 x diluted solution). From the pseudo first-order plots ( Figure S5 ) of the emitted fluorescence, we could conclude that only one of the two steps is rate determining, with a half-life of 19.25 mins. 
HPLC Kinetic Experiments: 1,3-Dipolar Cycloaddition
An acetonitrile stock of trans-cyclooctenol 10 was prepared at 100 mM or 200 mM, and a coumarin probe 8a stock was prepared at 5mM (Note: coumarin probe 8b experiments were run under similar conditions, a 100 mM stock was prepared with 17% DMSO and was further diluted in acetonitrile 20-fold to 5mM resulting in 0.85% DMSO). For the control experiment (run in triplicate), 100 µl of coumarin probe 8a stock (in acetonitrile) was added to a solution containing 400 µl acetonitrile and 500 µl PBS (total volume of 1 mL). Absorbance is measured at 254 nm, and the area under curve was used for pseudo first-order calculations.
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1 H NMR Product Distribution Experiments
In a typical 1 Table S1 , Table S2 , Figure S18 -S20. A representative example of the raw HPLC data is illustrated in Figure S21 and Figure S22 . Table S1, Table S2 , Figure S19 , and Figure S20 . A representative example of the raw HPLC data is illustrated in Figure S23 and Figure S24 . Table S1 . Stability and release studies of doxorubicin relative to peak area at time = 0 h. Table S2 . Doxorubicin 15 release from prodrug 9 (100 µM) in the presence and absence of TCO-OH major-10 (500 µM). Concentration of doxorubicin release was determined using the standard curve ( Figure S17 ) and used to calculate the percentage release (from the expected maximum concentration of doxorubicin). 
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Figure S19. Reaction of doxorubicin prodrug 9 (100 µM) with TCO-OH major-10 (500 µM) in 50% serum:PBS and PBS only. Shown for comparison is stability of 9 in 50% serum:PBS (also see Figure S18 ). Error bars represent ± SD (n = 3). 
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Typical rate determination assay for doxorubicin prodrug 9 in 50% mouse serum:PBS.
The second-order rate constant for doxorubicin prodrug 9 was measured using pseudo first-order kinetics (similar to section 5 rate calculations with coumarin probes 8a and 8b). In a typical experiment, the reaction of prodrug 9 (0.1 mM) with TCO-OH major-10 (10 mM) was incubated at 37 °C. A 15 L aliquot was taken at the indicated time points (0 h, 4 h, 24 h, 48 h) and diluted with 60 L of cold acetonitrile (5-fold dilution). The diluted sample was centrifuged (13,400 rpm) for 5 min, and the supernatant added to an HPLC vial (100 L insert). 50 L of the supernatant was injected onto the HPLC and analysed at 254 nm and 480 nm using the general HPLC method (see section 1 of S.I.). The experiment was repeated in triplicate (n = 3) to provide a second-order rate constant of 0.137 ± 0.012 M -1 s -1 ( Figure S25 ). 0  10  20  30  40  50  60  70  80  90  100  110  120  130  140  150  160  170  180  190  200  210  220  230 f1 (ppm) 0  10  20  30  40  50  60  70  80  90  100  110  120  130  140  150  160  170  180  190  200  210  220  230 f1 (ppm) 
